SMARCA4-deficient Non–small Cell Lung Cancer on 18F-FDG PET/CT
Clinical Nuclear Medicine Open · 2025
DOI: 10.1097/nm9.0000000000000014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2025. Verfasst von Tao Liu und 6 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A 70-year-old man, a heavy smoker, presented with multiple lesions in both lungs during a computed tomography check-up. The largest nodule in the upper lobe of the right lung indicated a high malignancy risk. Subsequent positron emission tomography/computed tomography showed the largest nodule with a high avidity of 18 F-FDG (SUVmax: 5.59). Curative surgery removed the nodule, and pathologic examination confirmed that the nodule was SMARCA4-deficient non–small cell lung cancer.
Zitieren
APA
Liu, T., Ji, H., Jiang, S., Qi, R., Zhou, X., Sun, J., & Wu, J. (2025). SMARCA4-deficient Non–small Cell Lung Cancer on 18F-FDG PET/CT. Clinical Nuclear Medicine Open. https://doi.org/10.1097/nm9.0000000000000014
Vancouver
Liu T, Ji H, Jiang S, Qi R, Zhou X, Sun J, et al. SMARCA4-deficient Non–small Cell Lung Cancer on 18F-FDG PET/CT. Clinical Nuclear Medicine Open. 2025. doi:10.1097/nm9.0000000000000014
BibTeX
@article{Liu2025,
author = {Liu, Tao and Ji, Hengshan and Jiang, Siyuan and Qi, Rongxin and Zhou, Xiaodie and Sun, Jingjing and Wu, Jiang},
title = {SMARCA4-deficient Non–small Cell Lung Cancer on 18F-FDG PET/CT},
journal = {Clinical Nuclear Medicine Open},
year = {2025},
doi = {10.1097/nm9.0000000000000014}
}
EUVIMED